Evidence map›Paper›PMID 41797001›Full record

ArticlemAbs2026

NAStructuralDB : structural database to facilitate computational studies of molecular modeling and recognition of proteins with special focus on antibody-antigen interactions.

Dawid Chomicz, Paweł Dudzic, Sonia Wrobel, Tomasz Gawlowski, Samuel Demharter, Roberto Spreafico, Hervé Minoux, Andrew Phillips, Konrad Krawczyk

Abstract read
In one paragraph

Article in mAbs, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Dawid ChomiczR&D Department, Natural Antibody, Szczecin, Poland.ORCID 0009-0000-7943-6082
Paweł DudzicR&D Department, Natural Antibody, Szczecin, Poland.ORCID 0009-0006-3849-7640
Sonia WrobelR&D Department, Natural Antibody, Szczecin, Poland.ORCID 0000-0002-7921-2334
Tomasz GawlowskiR&D Department, Natural Antibody, Szczecin, Poland.
Samuel DemharterData Science Department, Genmab BV Discovery Data Science, Utrecht, Netherlands.ORCID 0000-0001-7352-3994
Roberto SpreaficoData Science Department, Genmab BV Discovery Data Science, Utrecht, Netherlands.ORCID 0000-0001-8282-7658
Hervé MinouxDigital R&D Department, Sanofi, Vitry-Sur-Seine, France.ORCID 0000-0002-0939-7310
Andrew PhillipsDigital R&D Department, Sanofi, Cambridge, UK.
Konrad KrawczykR&D Department, Natural Antibody, Szczecin, Poland.ORCID 0000-0003-0697-5522

Funding

project ‘Development of the Specitope technology for bioinformatics-based prediction of B-cell-specific epitopes, enabling the ‘in silico’ identification of candidates for therapeutic antibodies GRANT NO. FEMP.01.01-IP.01-0319/23-00
6 · The paper itself

Abstract

Studying the interactions between antibodies and antigens is fundamental to the development of novel therapeutic biologics. Predictions of such interactions start with data collection. Though there exist reliable resources to identify antibody structures in the Protein Data Bank (PDB), such data still requires substantial processing to be usable in predictive tasks. Redundancy in sequences needs to be removed to avoid data leakages between train, test, and validation sets. Descriptors such as surface accessibility, secondary structure, and antibody region information need to be additionally annotated. Information on inter- and intra-molecular contacts, which is crucial to studying paratope/epitope information, needs to be collected. The specialized immunoglobulin format of Nanobodies® requires a separate dataset mirroring that of antibodies, given that their structure contains only a single VHH chain. Because antibody-antigen structures account for a small amount of all protein-protein contacts, having a molecular contact reference from other proteins is also desired. To address these issues, we introduce NAStructuralDB (https://naturalantibody.com/na-structural/), a dataset of processed structures of antibodies, Nanobodies®, proteins, and their complexes with molecular contact information and associated annotations. We use the opportunity of having collected the contact data to provide a reference of binding propensities of different residues across distinct contact types.

Indexed as

AntigensComputational BiologyDatabases, ProteinModels, MolecularSingle-Domain AntibodiesEpitopesHumansProtein ConformationAntigensEpitopesSingle-Domain AntibodiesArtificial intelligencedatabaseprotein design

Identifiers

PMID41797001
PMCPMC12973472

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.